Novartis to cut 1,400 jobs in Switzerland - report - Breaking The News
Download our appPlay StoreApp Store

Novartis to cut 1,400 jobs in Switzerland - report

EPA-EFE/GEORGIOS KEFALAS

Novartis is planning to cut up to 1,400 jobs in Switzerland, Tages-Anzeiger reported on Tuesday.

According to the report, the Swiss pharmaceutical giant informed its 11,600 employees in the country that 12% of its staff in the country will lose their jobs over the next three years.

The company is also said to be planning to lay off 8,000 of its 108,000 employees worldwide in an effort to cut costs by about $1 billion.

Related Stocks
Novartis
Related News
Novartis to buy Anthos Therapeutics for up to $3.1B
Swiss pharmaceutical corporation Novartis AG agreed to acquire Anthos Therapeutics, Inc. for up to $3.1 billion, Blackstone Life Sciences and Anthos Therapeutics revealed in a press release on Tuesday.Under the agreement, Anthos shareholders will receive an upfront payment of $925 million at the closing of the transaction. In addition, they will get additional payments based on the successful achievement of specific regulatory and commercial...
Novartis' Q4 net sales surge 15% to $13.15 billion
Novartis AG announced on Friday that its net sales in the fourth quarter of the fiscal year 2024 observed an annual rise of 15% to reach $13.15 billion. The pharmaceutical company's net income increased by 7% compared to the same trimester the year before to hit $2.82 billion, while its operating income jumped by 37% to $3.53 billion. Meanwhile, its earnings per share (EPS) surged 10% year-over-year to land at $1.42. Furthermore, the corporation's free...
Novartis' Q2 EPS surge by 116% to $1.58
Novartis AG announced on Tuesday that its net sales in the third quarter of the fiscal year 2024 observed an annual rise of 9% to hit $12.82 billion.The pharmaceutical company's net income soared by 111% compared to the same trimester the year before to reach $3.18 billion, while its operating income jumped by 106% to $3.63 billion. Meanwhile, its earnings per share (EPS) skyrocketed year-on-year by 116% to $1.58. Furthermore, the corporation's free...
Novartis Q2 EPS up 47% to $1.60
Novartis AG announced on Thursday that its earnings per share (EPS) in the second quarter of fiscal 2024 in USD terms surged 47% year-over-year, to reach $1.60.In the reported three-month period, net sales increased 9 on an annual basis, to stand at $12.5 billion. Net income in the third quarter jumped 43% compared to the same timeframe a year ago, amounting to $3.2 billion, while operating income stood at $4 billion, soaring 43%. Meanwhile, core EPS...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.